通过 LTK 的信号转导
中文名称
通路描述
Leukocyte tyrosine kinase (LTK) 是一种跨膜受体酪氨酸激酶,属于胰岛素样生长因子受体超家族。LTK 与 ALK 受体关系最密切,可能源于 ALK 基因的重复事件(Krowelski and Dalla-Favera, 1991; Dornburg et al, 2021)。ALK 和 LTK 的胞外域均具有膜近端 EGF 样(EGFL)模块、一个独特的 250 个氨基酸甘氨酸富集(GR)域以及一个 TNF 样(TNFL)模块。ALK ECD 还含有两个 MAM 结构域,包括 LDLa 域和肝素结合域(HBD),这些结构域在 LTK 受体中不存在(Iwahara et al, 1997; Morris et al, 1997; DeMunck et al, 2021)。这些 ECD 的差异可能影响两种受体的配体结合亲和力。LTK 由 ALKAL1 和 ALKAL2 配体结合胞外域激活(Zhang et al, 2014; Reshetnyak et al, 2015; Reshetnyak et al, 2018)。配体结合诱导受体胞内域的自磷酸化,促进下游信号分子(如 SHC、IRS1、CBL 和 PI3K)与磷酸化受体的相互作用和激活(Kozutsumi et al, 1994; Honda et al, 1994; Ueno et al, 1995; Ueno et al, 1996; Ueno et al, 1997; Li et al, 2004; Yamada et al, 2008)。然而,关于 LTK 早期功能研究的许多工作是在 ALKAL1 和 2 作为生理配体被鉴定之前进行的。因此,许多研究使用了融合受体,这些融合受体由已知受体的胞外域(包括刺激配体)与 LTK 的胞内域融合而成。LTK 信号的确切作用尚未完全阐明。上述融合 LTK 蛋白的表达促进轴突生长和细胞存活(Ueno et al, 1997; Yamada et al, 2008)。LTK 在调节从内质网到高尔基体的运输中的作用也被提出,一项研究表明 LTK 可能实际上是一种内质网驻留蛋白(Farhan et al, 2010; Centonze et al, 2019)。最近,LTK 的融合蛋白在小细胞肺癌中被鉴定(Izumi et al, 2021)。
英文描述
Transcriptional and post-translational regulation of MITF-M expression and activity Melanocytes, neurons and glia all arise from precursor cells derived from neural crest cells. Cells that will give rise to neurons and glia migrate away from the neural crest earlier and in a ventral pattern, while cells that will give rise to melanocytes leave the neural crest later and migrate dorsolaterally. Nevertheless, melanocytes can also arise in an alternate pathway from dual Schwann cell/melanocyte precursors or by dedifferentiation from Schwann cells, a derivative of the glial lineage (reviewed in Mort et al, 2015). MITF-M is a key regulator of melanocyte development, and its expression distinguishes the melanocyte fate from that of glial and neural cells. MITF-M expression is repressed in precursors through the activity of FOXD3 and SOX2. Depending on the species, these transcription factors may either bind directly to elements in the MITF-M promoter to repress transcription, or may act independently of DNA binding by disrupting protein-protein interactions that promote transcriptional activity (Nitzan et al, 2013a,b; Curran et al, 2009, 2010; Adameyko et al, 2012; reviewed in Mort et al, 2015; White and Zon, 2008; Goding and Arnheiter, 2019). FOXD3 and SOX2 expression, in turn, are regulated by a cascade of other transcription factors, including ZIC1, PAX3, SNAIL2 and SOX9 (reviewed in Mort et al, 2015; Goding and Arnheiter, 2019).
Relief of FOXD3 mediated repression may depend in part on HDAC1, as well as on down regulation of SNAIL2 (Ignatius et al, 2008; Greenhill et al, 2011; Nitzan et al, 2013a, b). MITF-M expression in unpigmented but committed melanoblasts depends on PAX3 and SOX10 binding at the promoter as well as on WNT, EDNRB and KIT signaling (reviewed in Mort et al, 2015; White and Zon, 2008; Goding and Arnheiter, 2019). Initial expression of MITF-M also contributes to downregulation of FOXD3 and SOX2 establishing a positive feedback loop that reinforces commitment to the melanocyte fate (reviewed in Mort et al, 2015; Goding and Arnheiter, 2019).
In addition to transcriptional regulation, MITF-M activity is also controlled by post translational modifications, although the significance of these modifications is not always clear. SUMOylation, ubiquitination and phosphorylation downstream of MAPK, WNT and AKT signaling can all impact the stability, localization or activity of MITF-M (reviewed in Goding and Arnheiter, 2019), and acetylation regulates the occupancy of target promoters, decreasing occupancy at differentiation-specific promoters (Louphrasitthiphol et al, 2020, 2023).
Relief of FOXD3 mediated repression may depend in part on HDAC1, as well as on down regulation of SNAIL2 (Ignatius et al, 2008; Greenhill et al, 2011; Nitzan et al, 2013a, b). MITF-M expression in unpigmented but committed melanoblasts depends on PAX3 and SOX10 binding at the promoter as well as on WNT, EDNRB and KIT signaling (reviewed in Mort et al, 2015; White and Zon, 2008; Goding and Arnheiter, 2019). Initial expression of MITF-M also contributes to downregulation of FOXD3 and SOX2 establishing a positive feedback loop that reinforces commitment to the melanocyte fate (reviewed in Mort et al, 2015; Goding and Arnheiter, 2019).
In addition to transcriptional regulation, MITF-M activity is also controlled by post translational modifications, although the significance of these modifications is not always clear. SUMOylation, ubiquitination and phosphorylation downstream of MAPK, WNT and AKT signaling can all impact the stability, localization or activity of MITF-M (reviewed in Goding and Arnheiter, 2019), and acetylation regulates the occupancy of target promoters, decreasing occupancy at differentiation-specific promoters (Louphrasitthiphol et al, 2020, 2023).
所含基因
62 个基因
AIMP1
AIMP2
AKT3
ALX3
CDH1
CREB1
CREBBP
CSF1
CTNNB1
DARS
EDN1
EDN3
EDNRB
EEF1E1
EP300
EPRS
FOXD3
GSK3B
HDAC1
HINT1
IARS
ID1
KARS
KIT
KITLG
LARS
LEF1
MAPK1
MAPK3
MARK3
MARS
MC1R
MC3R
MC4R
MC5R
MITF
PAX3
POMC
POU3F2
QARS
RARS
RPS6KA1
SIRT1
SNAI2
SOX10
SOX2
SOX9
SUMO1-C93-UBE2I
TBX3
TFE3
TFEB
TFEC
TNFSF11
UBE2I
UBE2I-G97-SUMO1
XPO1
YWHAB
YWHAE
YWHAG
YWHAH
YWHAZ
ZIC1